cariprazine 1.5/3 mixed pack

RxCUI: 1741746
RxNorm name: cariprazine 1.5/3 mixed pack
Display name: cariprazine 1.5/3 mixed pack
Full name: cariprazine 1.5/3 mixed pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vraylar	CARIPRAZINE	Allergan, Inc.	4b5f7c65-aa2d-452a-b3db-bc85c06ff12f	2025-12-18	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1741746

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4b5f7c65-aa2d-452a-b3db-bc85c06ff12f	cariprazine 1.5/3 mixed pack	SY	30	These highlights do not include all the information needed to use VRAYLAR safely and effectively. See full prescribing information for VRAYLAR . VRAYLAR ® ( cariprazine ) c apsules , for o ral u se Initial U.S. Approval: 2015	20251218
4b5f7c65-aa2d-452a-b3db-bc85c06ff12f	cariprazine 1.5/3 mixed pack	PSN	30	These highlights do not include all the information needed to use VRAYLAR safely and effectively. See full prescribing information for VRAYLAR . VRAYLAR ® ( cariprazine ) c apsules , for o ral u se Initial U.S. Approval: 2015	20251218
4b5f7c65-aa2d-452a-b3db-bc85c06ff12f	{1 (cariprazine 1.5 MG Oral Capsule) / 6 (cariprazine 3 MG Oral Capsule) } Pack	GPCK	30	These highlights do not include all the information needed to use VRAYLAR safely and effectively. See full prescribing information for VRAYLAR . VRAYLAR ® ( cariprazine ) c apsules , for o ral u se Initial U.S. Approval: 2015	20251218